retatrutide nonalcoholic steatohepatitis trial Liraglutide safety and efficacy in patients with non-alcoholic (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study Triple hormone receptor agonist retatrutide

For broader context on this developing medication, see Retatrutide Access and Safety

In addition, recent studies suggest that GLP-1s may be linked with a rare yet serious condition called nonarteritic anterior ischemic optic neuropathy (NAION)

Physician-Assisted Weight Loss Clinic As we develop a weight loss goal together, we take into account your nutritional preferences and daily activity

In the United States alone, the number of patients starting GLP-1 treatments for non-diabetic purposes has increased by 700% since 2019, with estimates suggesting that over 220,000 patients started treatment each month in 2024

If you have persistent vomiting or diarrhea, can't keep fluids down, or notice signs of severe dehydration, contact your medical team promptly: that's a moment for clinical guidance, not for pushing through